compostos que seletivamente modulam o receptor cb2

Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

Saved in:
Bibliographic Details
Main Authors Eugene Richard Hickey, Innocent Mushi, Renee M. Zindell, Angela Berry, Achim Sauer, Stephen Peter East, Monika Ermann, Someina Khor, Alessandra Bartolozzi, Lifen Wu, Patricia Amouzegh, Markus Ostermeier, David Smith Thomson, Doris Riether, Nigel Jamaes Blumire
Format Patent
LanguagePortuguese
Published 24.09.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Bibliography:Application Number: BR2009PI19024